- Session I
- Session II
- Session III
- Session IV
- Poster Sessions
Session I: Population Sciences and Health Disparities Chair: Theresa Keegan, Ph.D. |
|
8:00-8:15 am | Introduction and Welcome Primo Lara, M.D. Director, UC Davis Comprehensive Cancer Center |
8:15-8:45 am | Keynote Presentation: Cancer Health Disparities: Considering Structural Context, and Multilevel Social Determinants of Health Scarlett Lin Gomez, M.P.H., Ph.D. Professor, Epidemiology & Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco |
8:45-9:00 am | Q&A |
9:00-9:15 am | Gastrointestinal Cancers in Primary Sclerosing Cholangitis Christopher Bowlus, M.D. Lena Valente Professor and Chief, Division of Gastroenterology and Hepatology, University of California, Davis |
9:15-9:20 am | Q&A |
9:20-9:35 am | Genetic Ancestry and Subtype-Specific Breast Cancer Risk in Latin American Women Laura Fejerman, Ph.D. Associate Professor, Division of Epidemiology, Department of Public Health Sciences, School of Medicine; Co-Director, Women’s Cancer Care Program; Leader, Latinos United for Cancer Health Advancement (LUCHA) Initiative, Comprehensive Cancer Center, University of California, Davis |
9:35-9:40 am | Q&A |
9:40-9:55 am | A Series of Implementation Strategies to Increase Reach for Tobacco Treatment with Cancer Patients Elisa Tong, M.D., M.A. Associate Professor, Division of General Internal Medicine; Medical Director, Stop Tobacco Program, Comprehensive Cancer Center, University of California, Davis |
9:55-10:00 am | Q&A |
10:00-10:15 am | Treatments for Clinically Localized Prostate Cancer: Systematic Review and Evidence Visualization Joshua Fenton, M.D., M.P.H. Professor and Co-Vice Chair of Research, Department of Family and Community Medicine, University of California, Davis |
10:15-10:20 am | Q&A |
10:20-10:30 am | Break |
Session II: Spotlight on Junior Investigators Chair: Frederick Meyers, M.D., M.A.C.P. |
|
10:30-11:00 am | Keynote Presentation: Diversifying and Training the Next Generation of Cancer Researchers Eileen Dolan, Ph.D. Professor of Medicine, Associate Director for Cancer Education; Chair, Committee on Clinical Pharmacology and Pharmacogenomics, Comprehensive Cancer Center, University of Chicago |
11:00-11:15 am | Q&A |
11:15-11:25 am | The TP53 P72R SNP Alters Allelic Selection and Affects the Behavior of Mutant p53 in Human Cancer Cristabelle De Souza, Ph.D. Department of Biochemistry and Molecular Medicine, UC Davis Medical Center; University of New Mexico Biomedical Sciences Graduate Program |
11:25-11:30 am | Q&A |
11:30-11:40 am | Modeling Familial Pancreatic Cancer with CRISPR/Cas9 to Develop Personalized Cancer Therapy Keely Ji Department of Microbiology and Molecular Genetics, University of California, Davis |
11:40-11:45 am | Q&A |
11:45-11:55 am | Ketogenic Diet Mitigates Cachexia in a Pancreatic Ductal Adenocarcinoma Mouse Model Natalia E. Cortez Department of Nutrition, University of California, Davis |
11:55-12:00 pm | Q&A |
12:00-12:10 pm | Break |
12:10-12:45 pm | Poster Sessions – Block A1 -A4 |
12:50-1:25 pm | Poster Sessions – Block A5 and B1 |
1:30-1:40 pm | A Novel Approach for Understanding Metastatic Pathways Between Sarcoma Subtypes and Its Potential to Identify New Therapies for Patients Maria Muñoz Division of Hematology Oncology, Department of Internal Medicine, University of California, Davis |
1:40-1:45 pm | Q&A |
1:45-1:55 pm | Evaluation of Novel Galectin-1 Inhibitors in Pancreatic Cancer Brandy A. Weathers Department of Nutrition, University of California, Davis |
1:55-2:00 pm | Q&A |
2:00-2:10 pm | The Role of Radiation Therapy in Addition to Lumpectomy and Hormone Therapy in Men 70 Years of Age and Older with Early Breast Cancer: A NCDB Analysis Lauren M. Perry, M.D. Division of Surgical Oncology, Department of Surgery, University of California, Davis Medical Center |
2:10-2:15 pm | Q&A |
2:15-2:30 pm | Break |
SESSION III: Basic/Translational Science Chair: Luis Carvajal-Carmona, Ph.D. |
|
2:30-3:00 pm | Keynote Presentation: Biological and Genetic Factors Influencing Disparities: A Novel DNA Repair Mechanism Associated with Triple Negative Breast Cancer in African Americans John D. Carpten, Ph.D. Professor, USC Department of Urology Chair, USC Department of Translational Genomics Director, USC Institute for Translational Genomics Director, USC Molecular Genomics Core Co-Leader, Norris Comprehensive Cancer Center |
3:00-3:15 pm | Q&A |
3:15-3:30 pm | Phase 1 Clinical Trial of Inhaled Recombinant Human IL-15 in Dogs with Pulmonary Metastasis Robert B. Rebhun, D.V.M., Ph.D., D.A.C.V.I.M. (Oncology) Professor and Maxine Adler Endowed Chair in Oncology School of Veterinary Medicine, University of California, Davis |
3:30-3:35 pm | Q&A |
3:35-3:50 pm | Translational Immuno-Oncology at UC Davis Arta Monir Monjazeb, M.D., Ph.D. Associate Professor of Radiation Oncology CCSG Staff Investigator for Immunotherapy Laboratory of Cancer Immunology, Comprehensive Cancer Center, University of California, Davis |
3:50-3:55 pm | Q&A |
3:55-4:10 pm | Targeting Immunosuppressive Factor CD47 in Cancer Radiotherapy Jian-Jian Li, M.D., Ph.D. Professor Department of Radiation Oncology, School of Medicine, University of California, Davis |
4:10-4:15 pm | Q&A |
4:15-4:30 pm | Translation Initiation and Cancer: Structural Insight into the Mechanism of mRNA Recruitment and Scanning Christopher S. Fraser, Ph.D. Professor, Department of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis |
4:30-4:35 am | Q&A |
8:00-8:35 am | Poster Session – Block C1 – C4 |
8:40-9:15 am | Poster Session – Block D1 – D2 |
SESSION IV: Clinical Research Chair: Karen Kelly, M.D. |
|
9:30-10:00 am |
Keynote Presentation: |
10:00-10:15 am | Q&A |
10:15-10:30 pm | Up is Down and Down is Up - Update on Donor Selection and GvHD Prevention Strategies in Allogeneic Stem Cell Transplantation Rasmus Hoeg, M.D. Assistant Professor of Medicine, University of California, Davis |
10:30-10:35 am | Q&A |
10:35-10:50 am | The UCHMC Multiple Myeloma Working Group: Successes, Setbacks and Future Directions Aaron Seth Rosenberg, M.D., M.S. Assistant Professor of Medicine, University of California, Davis |
10:50-10:55 am | Q&A |
10:55-11:10 am | The Future of Cellular Therapy Mehrdad Abedi, M.D. Professor of Medicine, Director, Alpha Stem Cell Clinic, University of California, Davis |
11:10-11:15 am | Q&A |
11:15-11:25 am | Closing Remarks and Poster Awards Announcement Primo Lara, M.D. Director, UC Davis Comprehensive Cancer Center |
Poster presentations will be delivered simultaneously in blocks with three to five posters in each block. Please see “poster schedule” for details.